Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity

Mar 30, 2026Diabetes, metabolic syndrome and obesity : targets and therapy

How High Blood Sugar and Fat Damage Work Together in Diabetic Kidney Disease

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗OA ↗

Abstract

Diabetic kidney disease affects approximately 40% of patients with diabetes.

Residual renal risk persists despite intensive glycemic control, indicating a complex metabolic origin of diabetic kidney disease.
may serve as a central hub linking glucotoxicity and lipotoxicity, contributing to kidney injury.
Key pathogenic mechanisms include the suppression of autophagy via the TXNIP-mTOR axis and the promotion of insulin resistance through DAG-PKC signaling.
Activation of the NLRP3 inflammasome is associated with increased oxidative stress and mitochondrial dysfunction.
Emerging multi-target therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, could provide new avenues for preserving renal function.

AI simplified

Diabetic kidney disease (DKD) affects approximately 40% of patients with diabetes and remains the leading cause of end-stage renal disease globally, posing a critical public health challenge. While hyperglycemia has long been considered the primary driver, the persistence of residual renal risk despite intensive glycemic control highlights a critical gap in our understanding of the disease's multifaceted metabolic origins. This review addresses this gap by shifting the focus beyond the "gluco-centric" paradigm to the synergistic lethality of "." We synthesize evidence showing how acts as a central hub connecting glucotoxicity and lipotoxicity, triggering a self-perpetuating vicious cycle of injury. Specifically, we dissect the molecular crosstalk across key pathogenic nodes, including the TXNIP-mTOR axis suppressing autophagy, DAG-PKC signaling driving insulin resistance, and the activation of the NLRP3 inflammasome. These intersecting pathways converge to accelerate oxidative stress, mitochondrial dysfunction, and fibrosis. We conclude by discussing the clinical implications of this metabolic framework, emphasizing how emerging multi-target therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, offer a translational pathway from mechanistic insights to precision medicine for preserving renal function.

Key numbers

48.6%

Kidney Failure Rate

Proportion of kidney failure cases attributed to diabetic kidney disease.

40%

Prevalence of DKD

Percentage of diabetes patients affected by diabetic kidney disease.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

View full text (PDF) ↗

Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity

Abstract

Key numbers

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief

Abstract

Key numbers

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief